Prevention and mitigation of acute radiation syndrome in mice by synthetic lipopeptide agonists of Toll-like receptor 2 (TLR2)
about
New approaches to radiation protectionRadiation enteropathy--pathogenesis, treatment and preventionThe Toll-Like Receptor 5 Agonist Entolimod Mitigates Lethal Acute Radiation Syndrome in Non-Human PrimatesSuccinate ester derivative of δ-tocopherol enhances the protective effects against (60)Co γ-ray-induced hematopoietic injury through granulocyte colony-stimulating factor induction in miceTHE POTENTIATION OF THE RADIOPROTECTIVE EFFICACY OF TWO MEDICAL COUNTERMEASURES, GAMMA-TOCOTRIENOL AND AMIFOSTINE, BY A COMBINATION PROPHYLACTIC MODALITY.Inhibiting glycogen synthase kinase-3 mitigates the hematopoietic acute radiation syndrome in miceMedical Countermeasures for Radiation Exposure and Related Injuries: Characterization of Medicines, FDA-Approval Status and Inclusion into the Strategic National Stockpile.Tocols induce G-CSF and mobilise progenitors that mitigate radiation injuryAutophagy confers DNA damage repair pathways to protect the hematopoietic system from nuclear radiation injury.A critical role of toll-like receptor 2 (TLR2) and its' in vivo ligands in radio-resistanceMCI extraction from Turkish galls played protective roles against X-ray-induced damage in AHH-1 cells.Radiation takes its TollThe H-ARS Dose Response Relationship (DRR): Validation and Variables.Novel regenerative peptide TP508 mitigates radiation-induced gastrointestinal damage by activating stem cells and preserving crypt integrityPersistent Activation of the Innate Immune Response in Adult Drosophila Following Radiation Exposure During Larval Development.Patents for Toll-like receptor ligands as radiation countermeasures for acute radiation syndromeUse of biomarkers for assessing radiation injury and efficacy of countermeasuresAlpha-tocopherol succinate- and AMD3100-mobilized progenitors mitigate radiation combined injury in mice.TLR2 & Co: a critical analysis of the complex interactions between TLR2 and coreceptors.Radiation and inflammation.Radioprotective Agents: Strategies and Translational Advances.p53 and the Carcinogenicity of Chronic Inflammation.Modulation of inflammation and disease tolerance by DNA damage response pathways.Melatonin as an anti-inflammatory agent in radiotherapy.4-(Nitrophenylsulfonyl)piperazines mitigate radiation damage to multiple tissues.The Toll-Like Receptor 2/6 Agonist, FSL-1 Lipopeptide, Therapeutically Mitigates Acute Radiation Syndrome.Monophosphoryl lipid a attenuates radiation injury through TLR4 activation.The GS-nitroxide JP4-039 improves intestinal barrier and stem cell recovery in irradiated mice.Dynamics of wound healing signaling as a potential therapeutic target for radiation-induced tissue damage.
P2860
Q27005588-B1A5B62C-793A-4E10-8962-2B00C3DCC4B5Q28237189-FBBBAC3F-ED44-407A-83DE-F09DBEEA6DFEQ28548012-F6441A4D-143A-43B2-B61F-98026F7EC563Q28817753-85E92A3B-8B31-4BF9-AB95-23FC4693D747Q33728050-B3648450-DB0B-4008-8CCD-88C20F0F6049Q33841776-A8754D99-7110-4389-BB89-FF539FFBF475Q35566671-1F4A40FC-7B3B-4E2B-90CB-940634DBF44CQ35616543-4272BE82-F3D7-47E1-93CF-8B55EB2A5E04Q35869745-668FC019-9B04-4189-8160-F104A6225BA4Q35947809-09A4EC4C-554D-41A6-883F-3CDF5AF99BC2Q36014299-30F38286-B686-4150-9704-25810B06A4B3Q36083353-438E9C4C-612A-4DBB-8EC7-9C53FAAFB400Q36120987-0D25295A-5E05-4BB4-965F-5AED9417F477Q36225645-5FE982B8-EACD-49D0-8CE7-8E114200ED3EQ36245825-690E97A1-B726-4B6B-91E7-D9C550E31697Q36357104-60DC9C87-6484-42D3-90D6-40801C5AD369Q36519142-9E64FE79-6369-4891-B43A-8106D801F3EFQ37450638-E334C907-E4B3-40D0-AEEA-5E6B807B989AQ38132733-795E6CB0-89C6-4618-B6A1-80964CE9B37AQ38284081-087515D8-7C13-4EE0-BBFD-F0DAFE4FF51DQ38710560-1CFC9505-CF36-4EBE-A6AE-4BC8F481C452Q38934157-81EF58CA-43CB-4B9A-9ADE-210B48281EECQ38968135-5AAF17A5-575B-4252-8888-EAA5A8CD9A36Q39159265-0BF4AB46-3D58-4A9B-BB61-605CE661F65FQ41090290-BA2AA8B8-030B-41D8-99A1-9160A6BF05C6Q47125123-843B0522-BD1E-44BE-BC5C-22908633AAE1Q47134893-3F27840E-009B-467B-B2ED-7FD77C032FB6Q49389182-9740E536-6A5C-4C9A-A0AF-66470024FFFBQ51008144-7391581F-2B8A-453D-BBA9-3DD046E83363
P2860
Prevention and mitigation of acute radiation syndrome in mice by synthetic lipopeptide agonists of Toll-like receptor 2 (TLR2)
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Prevention and mitigation of a ...... of Toll-like receptor 2 (TLR2)
@ast
Prevention and mitigation of a ...... of Toll-like receptor 2 (TLR2)
@en
Prevention and mitigation of a ...... of Toll-like receptor 2 (TLR2)
@nl
type
label
Prevention and mitigation of a ...... of Toll-like receptor 2 (TLR2)
@ast
Prevention and mitigation of a ...... of Toll-like receptor 2 (TLR2)
@en
Prevention and mitigation of a ...... of Toll-like receptor 2 (TLR2)
@nl
prefLabel
Prevention and mitigation of a ...... of Toll-like receptor 2 (TLR2)
@ast
Prevention and mitigation of a ...... of Toll-like receptor 2 (TLR2)
@en
Prevention and mitigation of a ...... of Toll-like receptor 2 (TLR2)
@nl
P2093
P2860
P1433
P1476
Prevention and mitigation of a ...... of Toll-like receptor 2 (TLR2)
@en
P2093
Alec Cheney
Alexander N Shakhov
Andrei Gudkov
Christie M Orschell
Elena Feinstein
Frederick Bone
Jason Young
Michael M Weil
Patricia S Baker
Peter Krasnov
P2860
P304
P356
10.1371/JOURNAL.PONE.0033044
P407
P577
2012-01-01T00:00:00Z